Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Blood
|
August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
Cristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
Gastroenterology
|
May 24, 2015
Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease
Mala Setty, Valentina Discepolo, Valérie Abadie, et al.
American Journal of Hematology
|
February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia
Michael K Jones, Jesse Sanchez, Megan Connor, et al.
Eclinicalmedicine
|
October 27, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial
Daniel A Pollyea, Brett M Stevens, Diana Abbott, et al.
Nature Immunology
|
October 27, 2014
A central role for Notch in effector CD8(+) T cell differentiation
Ronald A Backer, Christina Helbig, Rebecca Gentek, et al.
Haematologica
|
April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
Jonathan A Gutman, Amanda Winters, Andrew Kent, et al.
American Journal of Hematology
|
August 7, 2025
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia
Somedeb Ball, Akriti G Jain, Najla Al Ali, et al.
Haematologica
|
February 26, 2026
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
Justin Watts, Ellen Madarang, Diana Abbott, et al.
The Veterinary Record
|
June 29, 2019
Call for coordinated antimicrobial approach at veterinary diagnostic laboratories
Fergus Allerton, John Fishwick, Susan Paterson, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Blood
|
August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
Cristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
Gastroenterology
|
May 24, 2015
Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease
Mala Setty, Valentina Discepolo, Valérie Abadie, et al.
American Journal of Hematology
|
February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia
Michael K Jones, Jesse Sanchez, Megan Connor, et al.
Eclinicalmedicine
|
October 27, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial
Daniel A Pollyea, Brett M Stevens, Diana Abbott, et al.
Nature Immunology
|
October 27, 2014
A central role for Notch in effector CD8(+) T cell differentiation
Ronald A Backer, Christina Helbig, Rebecca Gentek, et al.
Haematologica
|
April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
Jonathan A Gutman, Amanda Winters, Andrew Kent, et al.
American Journal of Hematology
|
August 7, 2025
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia
Somedeb Ball, Akriti G Jain, Najla Al Ali, et al.
Haematologica
|
February 26, 2026
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
Justin Watts, Ellen Madarang, Diana Abbott, et al.
The Veterinary Record
|
June 29, 2019
Call for coordinated antimicrobial approach at veterinary diagnostic laboratories
Fergus Allerton, John Fishwick, Susan Paterson, et al.
Page
of 7